OMFS - ETF AI Analysis
Top Page
Invesco Russell 2000 Dynamic Multifactor ETF (OMFS)
OMFS, the Invesco Russell 2000 Dynamic Multifactor ETF, earns a solid overall rating thanks to several strong holdings with healthy financial performance and growth, such as CareTrust REIT, Krystal Biotech, MYR Group, Terreno Realty, and Victory Capital, which bring robust revenues, positive earnings calls, and in some cases attractive dividends. The fund’s score is held back somewhat by weaker names like Silicon Laboratories and Acadian Asset Management, where declining or pressured financials, leverage, and valuation concerns add risk. The main risk factor is exposure to smaller companies whose valuations and technical signals can be volatile, even when fundamentals look strong.
OMFS vs. SPDR S&P 500 ETF (SPY)
- AUM
- 261.26M
- Region
- North America
- Expense Ratio
- 0.39%
- Beta
- 0.89
- Issuer
- Invesco
- Inception Date
- Nov 08, 2017
- Dividend Yield
- 1.31%
- Asset Class
- Equity
- Index Tracked
- Russell 2000 Invesco Dynamic Multifactor Index
OMFS Summary
The Invesco Russell 2000 Dynamic Multifactor ETF (OMFS) is a fund that invests in smaller U.S. companies by tracking the Russell 2000 Invesco Dynamic Multifactor Index. It holds a wide mix of businesses, including financial firms, health care companies, technology names, and real estate owners like CareTrust REIT and Terreno Realty. Investors might consider OMFS if they want growth potential from small-cap stocks and diversification across many sectors, rather than betting on just a few companies. However, because it focuses on smaller firms, the share price can be more volatile and can go up and down sharply with changes in the market.
How much will it cost me?
The Invesco Russell 2000 Dynamic Multifactor ETF (OMFS) has an expense ratio of 0.39%, meaning you’ll pay $3.90 per year for every $1,000 invested. This is slightly higher than average for ETFs because it uses an actively managed multifactor strategy to adjust its portfolio dynamically, rather than passively tracking an index.
What would affect this ETF?
The OMFS ETF, focused on U.S. small-cap companies, could benefit from economic growth and innovation in sectors like technology and health care, which are key components of its portfolio. However, it may face challenges from rising interest rates or economic slowdowns, which tend to impact smaller companies more significantly. Regulatory changes or sector-specific disruptions, particularly in financials and industrials, could also influence its performance.
OMFS Top 10 Holdings
OMFS is leaning into U.S. small caps with a noticeable tilt toward financials and real estate, and that’s where much of the action is. FirstCash and Terreno Realty have been steady climbers this year, helping keep the fund’s engine humming, while CareTrust REIT has lost some steam lately and Piper Sandler has been dragging performance. On the growth side, Silicon Laboratories and Acadian Asset Management have been rising sharply, adding a tech-and-quality flavor to the mix. Overall, it’s a domestically focused, factor-driven basket with a few standout winners offsetting some laggards.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 CTRE | CareTrust REIT | 1.64% | $4.29M | $8.47B | 3.58% | 80Outperform |
 FCFS | FirstCash | 1.60% | $4.18M | $9.32B | 36.51% | 74Outperform |
 SSRM | SSR Mining | 1.37% | $3.58M | $6.42B | 32.65% | ―― |
 EAT | Brinker International | 1.15% | $3.01M | $8.29B | 54.78% | 70Neutral |
 TRNO | Terreno Realty | 1.18% | $3.08M | $6.98B | 5.03% | 75Outperform |
 MYRG | MYR Group | 1.15% | $3.01M | $4.44B | 36.98% | 76Outperform |
 SLAB | Silicon Laboratories | 1.11% | $2.91M | $7.37B | 62.36% | 56Neutral |
 KRYS | Krystal Biotech | 0.99% | $2.59M | $9.48B | 68.35% | 80Outperform |
 AAMI | Acadian Asset Management | 0.93% | $2.43M | $3.31B | 101.08% | 66Neutral |
 VCTR | Victory Capital Holdings | 0.90% | $2.35M | $6.67B | 64.89% | 80Outperform |
OMFS Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For OMFS, the sentiment is Negative. The current price of 48.93 is below the 20-day moving average (MA) of 49.62, below the 50-day MA of 51.19, and below the 200-day MA of 49.43, indicating a bearish trend. The MACD of -0.58 indicates Negative momentum. The RSI at 37.40 is Neutral, neither overbought nor oversold. The STOCH value of 28.64 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for OMFS.
OMFS Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| OMFS | $48.93 | $53.00(8.32% Upside) | $261.26M | 0.39% | 67Neutral |
 SFLO | $38.97 | $48.03(23.24% Upside) | $843.36M | 0.49% | 68Neutral |
 OUSM | $47.47 | $53.97(13.69% Upside) | $797.99M | 0.48% | 72Outperform |
 BBSC | $83.46 | $108.26(29.72% Upside) | $713.10M | 0.09% | 63Neutral |
 EES | $64.91 | $79.29(22.16% Upside) | $675.71M | 0.38% | 67Neutral |
 JHSC | $45.85 | $56.40(23.01% Upside) | $673.26M | 0.42% | 67Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| OMFS | Invesco Russell 2000 Dynamic Multifactor ETF | 48.93 | 5.40 | 12.40% | |
| SFLO | VictoryShares Small Cap Free Cash Flow ETF | 38.97 | 10.40 | 36.43% | |
| OUSM | OShares U.S. Small-Cap Quality Dividend ETF | 47.47 | 3.71 | 8.48% | |
| BBSC | JPMorgan BetaBuilders U.S. Small Cap Equity ETF | 83.45 | 8.70 | 11.64% | |
| EES | WisdomTree U.S. SmallCap Fund | 64.91 | 10.18 | 18.60% | |
| JHSC | John Hancock Multifactor Small Cap ETF | 45.85 | 4.18 | 10.03% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.